Sucampo Pharmaceuticals Inc., of Bethesda, Md., said its subsidiary, Sucampo AG, revised its exclusive global manufacturing and supply agreement with its manufacturing and development partner, R-Tech Ueno Ltd., of Tokyo, for clinical and commercial supplies of Amitiza (lubiprostone) in most global markets.